Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastases-free Survival”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Not applicableUnknownNCT06241092
What this trial is testing

AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma; Molecular Heterogeneity; Multi-model Analysis; Artificial Intelligence; Lymph Node Metastases; Disease-free Survival
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 256
Large-scale testing (Phase 3)Looking for participantsNCT04242017
What this trial is testing

Long-term Better Than Short-term ADT With Salvage RT

Who this might be right for
Prostate Cancer
Universitaire Ziekenhuizen KU Leuven 394
Testing effectiveness (Phase 2)Study completedNCT03142516
What this trial is testing

FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status

Who this might be right for
Colorectal NeoplasmsColorectal CarcinomaColorectal Cancer Metastatic+1 more
Grupo Espanol Multidisciplinario del Cancer Digestivo 20
Not applicableStudy completedNCT02385604
What this trial is testing

The Predictive Value of CT-PET in Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
St. James's Hospital, Ireland 250
Early research (Phase 1)WithdrawnNCT05375825
What this trial is testing

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Who this might be right for
Malignant Pleural Mesotheliomas (Mpm)Malignant Pleural Effusions (Mpe)Epithelial Tumors, Malignant+2 more
National Cancer Institute (NCI)
Not applicableNot Yet RecruitingNCT07636148
What this trial is testing

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

Who this might be right for
Liver Cancer (Primary and Metastatic)Lung Cancer (Diagnosis)Bone Cancer Metastatic+10 more
Mark C Burgmans, MD PhD 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT05726383
What this trial is testing

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

Who this might be right for
Osteogenic Sarcoma Recurrent
Hackensack Meridian Health 32
Large-scale testing (Phase 3)Looking for participantsNCT07426094
What this trial is testing

PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer

Who this might be right for
Prostate CancerBrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,600
Testing effectiveness (Phase 2)UnknownNCT04782765
What this trial is testing

Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal Carcinoma

Who this might be right for
Disease-free Survival Rate
Tianjin Medical University Cancer Institute and Hospital 59
Not applicableUnknownNCT04245410
What this trial is testing

Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma

Who this might be right for
Surgical ProcedureDisease Free SurvivalOverall Survival
Universidad de Extremadura 100
Not applicableUnknownNCT05845632
What this trial is testing

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

Who this might be right for
Carcinoma, Squamous CellSkin CancerCarcinoma, Squamous Cell, Skin+3 more
Maastricht University Medical Center 965
Large-scale testing (Phase 3)Looking for participantsNCT06952803
What this trial is testing

Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Who this might be right for
Prostate Cancer
AstraZeneca 700
Testing effectiveness (Phase 2)Ended earlyNCT04034251
What this trial is testing

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

Who this might be right for
Gastric AdenocarcinomaGastric CancerEsophagogastric Junction+1 more
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)Study completedNCT00286091
What this trial is testing

Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Amgen 1,435
Large-scale testing (Phase 3)Looking for participantsNCT06501482
What this trial is testing

Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI

Who this might be right for
Colorectal CancerColorectal Liver Metastases
Assistance Publique - Hôpitaux de Paris 254
Large-scale testing (Phase 3)Looking for participantsNCT05352178
What this trial is testing

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic+4 more
Universitaire Ziekenhuizen KU Leuven 873
Post-approval studies (Phase 4)UnknownNCT05229809
What this trial is testing

Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer

Who this might be right for
Gastric Carcinoma
Jie Li 212
Post-approval studies (Phase 4)Study completedNCT01129336
What this trial is testing

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

Who this might be right for
First or Second Line HER2-negative Breast CancerMetastatic Disease Without Bone Metastasis
Novartis Pharmaceuticals 44
Not applicableStudy completedNCT04495309
What this trial is testing

Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University Hospital Schleswig-Holstein 87
Testing effectiveness (Phase 2)Looking for participantsNCT06594926
What this trial is testing

Working Out M0 Bipolar Androgen Therapy

Who this might be right for
Prostate Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 69
Load More Results